16. Issued share capital, share premium account and share options

(a)

Share capital


	At March 31,
	2021	2020	2019
	€M	€M	€M
Authorized/Share Capital reorganization
1,550,000,000 ordinary equity shares of 0.600 euro cent each	9.3	9.8	9.3
1,368,000,000 'B' Shares of 0.050 euro cent each	0.7	0.7	0.7
1,368,000,000 Deferred shares of 0.050 euro cent each	0.7	0.7	0.7
	10.7	11.2	10.7
Allotted, called-up and fully paid:
1,089,181,737 ordinary equity shares of 0.600 euro cent each	—	6.5	—
1,133,395,322 ordinary equity shares of 0.600 euro cent each	—	—	6.8
1,128,062,028 ordinary equity shares of 0.600 euro cent each	6.7	—	—

In September 2020, 35.2m ordinary shares were issued via an ordinary share placing at a price of €11.35 per share generating approximately €400m proceeds. Transaction costs of approximately €2m were accounted for as a deduction from equity.

Other movement in the share capital balance year-on-year principally relates 3.6m new shares issued in fiscal year 2021, following the exercise of vested share options, (2020: 3m; 2019: nil). There were no share buybacks, resulting in no cancelled shares, in fiscal year 2021 (2020: 47.2m; 2019: 37.8m).

Ordinary equity shares do not confer on the holders thereof the specific right to be paid a dividend out of profits.

(b)

Share premium account


	At March 31,
	2021	2020	2019
	€M	€M	€M
Balance at beginning of year	738.5	719.4	719.4
Issue of ordinary equity shares	423.1	19.1	—
Balance at end of year	1,161.6	738.5	719.4

(c)Share options and share purchase arrangements

Option Plan 2013 allows employees or Directors to purchase shares in the Company up to an aggregate of approximately 5% (when aggregated with other ordinary shares over which options are granted and which have not yet been exercised) of the outstanding ordinary shares of Ryanair Holdings plc, subject to certain conditions. All grants are subject to approval by the Remuneration Committee. These are exercisable at a price equal to the market price of the ordinary shares at the time options are granted. The key terms of these option plans include the requirement that certain employees remain in employment with the Company for a specified period of time and that the Company achieves certain net profit targets and/or share price targets. At the 2019 AGM, shareholders approved LTIP 2019. LTIP 2019 replaces Option Plan 2013 for all future share based remuneration grants. There were no grants under LTIP 2019 in fiscal year 2021.

Details of the share options outstanding are set out below:


		Weighted
	Share Options	Average
	M	Exercise Price (€)
Outstanding at March 31, 2018	20.1		7.70
Exercised	—		—
Granted	20.0		11.12
Forfeited	(0.3)		12.00
Outstanding at March 31, 2019	39.8		9.38
Granted	—		—
Forfeited	(2.0)		12.47
Exercised	(3.0)		6.31
Outstanding at March 31, 2020	34.8		9.57
Granted	—		—
Forfeited	(1.2)		11.56
Exercised	(3.6)		6.42
Outstanding at March 31, 2021	30.0		9.83

The mid-market price of Ryanair Holdings plc’s ordinary shares on Euronext Dublin at March 31, 2021 was €16.55 (2020: €9.33; 2019: €11.67). The highest and lowest prices at which the Company’s shares traded on Euronext Dublin in fiscal year 2021 were €17.56 and €8.20 respectively (fiscal year 2020 were €16.07 and €8.32 respectively; fiscal year 2019 were €16.72 and €10.04 respectively). There were 10.9m options exercisable at March 31, 2021 (2020: nil; 2019: nil). The average share price for fiscal year 2021 was €13.01 (2020: €11.77; 2019: €13.28).

There were 3.6m options exercised during fiscal years 2021 (2020: 3.0m; 2019: nil).

At March 31, 2021 the range of exercise prices and weighted average remaining contractual life of outstanding options are shown in the table below.


		No.	Remaining
	Exercise	options	contractual
	price	outstanding	life
	€	M	(years)
Vested	6.25	3.6	1.3
Vested	6.74	2.2	1.5
Vested	8.35	5.0	1.6
	11.12	17.4	5.9
	12.00	1.6	3.4
	14.40	0.1	4.1
	17.55	0.1	1.3
Weighted average	9.83	30.0	4.1

The Company has accounted for its share option grants to employees at fair value, in accordance with IFRS 2, using a binomial lattice model to value the option grants. This has resulted in a charge of approximately €4m to the income statement (2020: €7m; 2019: €8m) being recognized within the income statement in accordance with employee services rendered.

A blend of the historical and implied volatilities of the Company’s own ordinary shares is used to determine expected volatility for share option granted. The weighted-average volatility is determined by calculating the weighted-average of volatilities for all share options granted in a given year. The expected term of share option grants represents the weighted-average period the awards are expected to remain outstanding. The service period is five years.